NeuroOne Announces First In Human Ablations Completed With OneRF Ablation System
Portfolio Pulse from Benzinga Newsdesk
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) announced the successful completion of the first human ablations using its OneRF Ablation System. The procedure was performed at a patient's bedside, saving time and costs associated with the operating room.
June 25, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeuroOne Medical Technologies Corporation announced the successful use of its OneRF Ablation System in a human patient, marking a significant milestone for the company. The procedure was performed at the patient's bedside, which could lead to cost savings and increased adoption of the technology.
The successful completion of the first human ablations using the OneRF Ablation System is a significant achievement for NeuroOne. Performing the procedure at the patient's bedside not only demonstrates the system's effectiveness but also highlights potential cost savings and operational efficiencies. This positive development is likely to boost investor confidence and positively impact NMTC's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100